Author: BusinessWire

The Screening Addresses Potential Approaches to Treating Emerging and Future Variants of SARS-CoV-2 Through Multi-Antibody Combination Therapy
VICTORIA, British Columbia–(BUSINESS WIRE)–$IPA #POLYTOPE–IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or…

The Screening Addresses Potential Approaches to Treating Emerging and Future Variants of SARS-CoV-2 Through Multi-Antibody Combination Therapy
VICTORIA, British Columbia–(BUSINESS WIRE)–$IPA #POLYTOPE–IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or…

The Screening Addresses Potential Approaches to Treating Emerging and Future Variants of SARS-CoV-2 Through Multi-Antibody Combination Therapy
VICTORIA, British Columbia–(BUSINESS WIRE)–$IPA #POLYTOPE–IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or…

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will be presenting a busines…

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will be presenting a busines…

DUBLIN–(BUSINESS WIRE)–The “BT524 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

BT524 is a human fibrinogen concentrate purified from human plasma. Fibrinogen is a plasmatic coagulation pr…

DUBLIN–(BUSINESS WIRE)–The “Saroglitazar Mg – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

SAROGLITAZAR Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gam…

DUBLIN–(BUSINESS WIRE)–The “Saroglitazar Mg – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

SAROGLITAZAR Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gam…

DUBLIN–(BUSINESS WIRE)–The “Saroglitazar Mg – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

SAROGLITAZAR Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gam…

DUBLIN–(BUSINESS WIRE)–The “Saroglitazar Mg – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

SAROGLITAZAR Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gam…